P194 - Toward elucidating the mechanism of local immunotherapy for brain cancer treatment Ulisse SALAZAR, Zürich, Switzerland Stand 1 Cancer immunology
|
|
P207 - Regulatory T cells modulate tumor-associated macrophages landscape during immune-suppressive recovery post chemotherapy.
Eléonore WEBER-DELACROIX, Paris, France
Stand 1
Cancer immunology
|
P157 - PD-1 in Peripheral T-cell Lymphoma: a therapeutic target using a novel approach by blocking and depleting hIgG1 antibody Sadjia BELKHELOUAT, Paris, France Stand 2 Cancer immunology
|
P178 - Tenascin-C orchestrates an immuno-suppressive tumor microenvironment with potential for targeting Thomas LOUSTAU, Strasbourg, France Stand 2 Cancer immunology
|
P158 - Effects of Intestinal Tumoral Alterations on the Liver Immune Environment Sraddha BHARADWAJ, Aachen, Germany Stand 2 Cancer immunology
|
P159 - Early and fast immune priming of pre-metastatic niches by tumor extracellular vesicles in a model of triple-negative breast cancer Louis BOCHLER, Strasbourg, France Stand 2 Cancer immunology
|
P198 - Development of an antitumor vaccine approach based on the delivery of messenger RNA Mohammed-Karim SEBANE, Strasbourg, France Stand 1 Cancer immunology
|
P192 - Non-Expressed Donor KIR3DL1 Alleles May Represent a Risk Factor for Relapse after T-Replete Haploidentical Hematopoietic Stem Cell Transplantation Christelle RETIÈRE, Nantes, France Stand 1 Cancer immunology
|
P175 - A new tumor escape mechanism tuned by HHLA2 Raphaëlle LEAU, Nantes, France Stand 2 Cancer immunology
|
P190 - The Tumor environment influences NK Cell receptor expression on MAIT cells Vanessa PROß, Berlin, Germany Stand 2 Cancer immunology
|
P197 - Cytotoxic function and efficiency of CD19 CAR T-cells from B-cell lymphoma patients analyzed by single cell, high resolution microscopy Eva C SCHWARZ, Homburg, Germany Stand 1 Cancer immunology
|
P163 - Development of CAR macrophages targeting alternative antigens in breast cancer Marie DUHAMEL, Villeneuve D'ascq, France Stand 2 Cancer immunology
|
P187 - Th17 cells target the metabolic miR142-5p-SDHC/SDHD axis promoting invasivness and progression of cervical cancers. Maike POHLERS, Homburg Saar, Germany Stand 2 Cancer immunology
|
P209 - Development of activated CAR macrophages for an anti-tumor immunotherapy strategy Lydia ZIANE CHAOUCHE , Villeneuve-D'ascq, France Stand 1 Cancer immunology
|
P170 - Immune landscape of vulvar cancer patients treated with surgery and adjuvant radiotherapy revealed restricted T cell functionality and increased IL-17 expression associated with cancer relapse Selina GIES, Homburg Saar, Germany Stand 2 Cancer immunology
|
|
P195 - TARGETING THE CXCR3-CHEMOKINE SYSTEM TO UNLEASH T-CELLS AGAINST SOLID CANCER
Sarah SCHULENBERG, Berlin, Germany
Stand 1
Cancer immunology
|
|
P162 - Enhanced priming of tumor specific CD8+ T cells by novel polymersome nanocarriers promotes anti-tumor immunity
Regine DRESS, Hamburg, Germany
Stand 2
Cancer immunology
|
P193 - Modulation of the soft tissue sarcoma T cell landscape by neoadjuvant hyperthermic radio(chemo)therapy Luise RUPP, Dresden, Germany Stand 1 Cancer immunology
|
|
P205 - The influence of Nras and Trp53 point mutations on melanoma plasticity and the tumor microenvironment
Saskia VADDER, Bonn, Germany
Cancer immunology
|
P176 - Keratinocyte-derived cytokine TSLP promotes growth and metastasis of melanoma by regulating the tumor-associated immune microenvironment Mei LI, Illkirch, France Stand 2 Cancer immunology
|
P167 - Achieving dendritic cell subset-specific targeting in vivo by site-directed conjugation of targeting antibodies and nanobodies to nanocarriers Michael FICHTER, Mainz, Germany Stand 2 Cancer immunology
|
|
P184 - Targeting of STAT3 in neutrophils promotes anti-tumoral neutrophil phenotype, inhibits tumor growth and reduces metastasis in murine transplantable head and neck tumor model
Irem OZEL, Essen, Germany
Stand 2
Cancer immunology
|
|
P161 - Identification of a new target on tumor-associated regulatory T cells involved in the inhibition of memory CD8 T cell functions
Justine CINIER, Lyon, France
Stand 2
Cancer immunology
|
P196 - Co-delivery of STING and TLR7/8 agonists in antigen-based nanocapsules to dendritic cells enhances CD8+ T cell-mediated melanoma remission Jenny SCHUNKE, 55131 Mainz, Germany Stand 1 Cancer immunology
|
O06 - Role of IL4-induced gene 1 expressing macrophages in melanoma Malvina SERADJ, Paris, France Stand 6 Dendritic and myeloid cells
|
P199 - Identification of fusion transcripts between the heavy chain of neonatal Fc receptor (FCGRT) and reticulocalbin 3 (RCN3) in Ewing sarcoma cells Martin S. STAEGE, Halle (Saale), Germany Stand 1 Cancer immunology
|
|
P183 - The influence of chemotherapy and checkpoint inhibition on the anti-tumoral immune response in head and neck cancer
Franziska OLIVERI, Ulm, Germany
Stand 2
Cancer immunology
|
P181 - Developing new strategies to control tumour progression – Targeting tumors or the immune system, a paradigm shift. Vincent MITTELHEISSER, Strasbourg, France Stand 2 Cancer immunology
|
P200 - Effects of melittin on gene expression in a dendritic cell/Hodgkin lymphoma co-culture model Martin STAEGE, Halle (Saale), Germany Stand 1 Cancer immunology
|
|
P204 - The Influence of Nras and Trp53 Point Mutations on Melanoma Plasticity and the Tumor Microenvironment
Saskia VADDER, Bonn, Germany
Cancer immunology
|
P201 - Respiratory but not systemic viral infection induces tumour growth inhibition through CD8+ T-cell activation. Philine STEINBACH, Essen, Germany Stand 1 Cancer immunology
|
|
P154 - Validation of a novel multiplex immuno-fluorescence panel for the spatial analysis of the tumor microenvironment
Mila BASIC, Tolochenaz, Switzerland
Stand 2
Cancer immunology
|
P177 - Age-related effects on tumor growth and metastatic progression: impact on immune populations in distant sites Cristina LIBONI, Strasbourg, France Stand 2 Cancer immunology
|
P164 - Tumor cell plasticity supports immune evasion and resistance to anti-PD-1 treatment by shaping the immune microenvironment in melanoma patients Anaïs EBERHARDT, Lyon, France Stand 2 Cancer immunology
|
P166 - Functional analysis on the single cell level Nora FEKETE-DRIMUSZ, Garbsen, Germany Robin KRÜGER, Garbsen, Germany Stand 2 Cancer immunology
|
O31 - Patient-derived lung cancer organoids as 3D-testing platform for precision CAR T-cell therapy Lukas EHLEN, Berlin, Germany Stand 2 Cancer immunology
|
P186 - Targeting interleukin-1β to improve chemoimmunotherapy in lung cancer Anaïs PERRICHET, Dijon, France Stand 2 Cancer immunology
|
O17 - Prostaglandin E2 curtails interleukin-2-dependent effector expansion from tumor-infiltrating stem-like CD8+ T cells to promote cancer immune escape Sebastian LACHER, Munich, Germany Stand 3 T cells
|
P208 - Development of a Mast-Cell Depleting Antibody for the Treatment of Mastocytosis William. P. M. WORRALL, Toulouse, France Stand 1 Cancer immunology
|
P185 - Interaction of Mesenchymal Stem/Stromal Cells with Immune Populations: Immunomodulation through Mitochondrial Transfer in the context of Allo-HSCT for patients with malignant hematological disorders Romain PEROUF, Vandoeuvre-Lès-Nancy, France Stand 2 Cancer immunology
|
OS15 - Contribution of CD44 expressed on Tumor-Associated Macrophages (TAMs) to progression of pancreatic cancer Nagwa IBRAHIM, Karlsruhe, Germany Stand 2 Cancer immunology
|
P172 - Identifying Pathophysiological Features of Mouse Tumors using Mass Cytometry Emilie GREGORI, Paris, France Stand 2 Cancer immunology
|
|
O13 - Regulation of tumor immunogenicity by splicing of transposable elements
Marianne BURBAGE, Paris, France
Stand 3
T cells
|
P180 - Bone marrow-derived cells impact metastases formation in pancreatic cancer Lisa-Marie MEHNER, Karlsruhe, Germany Stand 2 Cancer immunology
|
P174 - A plant-derived Virus Like Particle versatile platform for specific antigen-delivery to dendritic cells: towards the development of an innovative anti-tumor vaccine Armelle GUINGAND, Strasbourg, France Stand 2 Cancer immunology
|
P173 - High-Plex Co-Detection of RNA and Protein to Explore Tumor-Immune Interactions Utilizing RNAscope with Imaging Mass Cytometry Emilie GREGORI, Paris, France Stand 2 Cancer immunology
|
P182 - Harnessing innate immunity in cancer therapy and beyond: NLRP3 inflammasome activators Emilia NEUWIRT, Freiburg, Germany Stand 2 Cancer immunology
|
O24 - Immunosuppressive functions of cancer-associated fibroblasts in pancreatic cancer modulated by CD44 Sven TREFFERT, Karlsruhe, Germany Stand 5 Structural immunity: Stroma-immune crosstalk
|
|
P179 - A negative impact of circulating FoxP3+ Treg PD1high on antitumor CD4 th1 response during anti-PD(L)1 treatment
Amélie MARGUIER, Besançon, France
Stand 2
Cancer immunology
|
|
O14 - IL-2 is inactivated by the acidic pH environment of tumors enabling engineering of a pH-selective mutein
Silvia GAGGERO, Lille, France
Stand 3
T cells
|
|
P160 - MYB-dependent CD62L+ stem-like exhausted T cells mediate immune control upon checkpoint inhibition during chronic infection and cancer
Veit BUCHHOLZ, Munich, Germany
Stand 2
Cancer immunology
|
P171 - Immuno-Oncology Imaging Mass Cytometry of the Structural and Cellular Composition of the Tumor Microenvironmental in Human Cancers Emilie GREGORI, Paris, France Stand 2 Cancer immunology
|
|
P206 - Tools for canine cancer immunotherapy: Cross-reactivity of Approved Human Immune Checkpoint Blockers in Dogs and PBMC profiling with a 14-Color flow cytometry panel
Johannes VOM BERG, Schlieren, Switzerland
Stand 1
Cancer immunology
|
P203 - Nlrc5 deficiency promotes a tumour-permissive environment in a mouse model of human gastric B-cell lymphoma Dongmei TONG, Clayton, Australia Stand 1 Cancer immunology
|
P155 - Tumor-derived prostaglandin E2 programs cDC1 dysfunction to impair intratumoral orchestration of anti-cancer T cell responses Felix BAYERL, Munich, Germany Stand 2 Cancer immunology
|
P168 - The Chicken Embryo as a relevant model for Hepatocellular Carcinoma Paul GARCIA, Grenoble, France Stand 2 Cancer immunology
|
P191 - How do softened tumor cells escape immune surveillance Bin QU, Homburg, Germany Stand 2 Cancer immunology
|
P202 - Patient Tumor Derived Xenograft is a model allowing a better understanding of Follicular Helper T-cell Lymphoma oncogenesis Gamze TARI, Créteil, France Stand 1 Cancer immunology
|
O30 - Transcriptional signatures associated with persisting CD19 CAR T-cells in children with leukaemia Théo ACCOGLI, London, United Kingdom Stand 2 Cancer immunology
|
P169 - Extracellular vesicles and co-isolated endogenous retroviruses differently affect dendritic cells Federico COCOZZA, Paris Cedex 05, France 5 Cancer immunology
|
P156 - Combination immunotherapy in patients with rare cancers. Andreas BEHREN, Melbourne, Australia Stand 2 Cancer immunology
|
P165 - A comprehensive guided workflow for highplex imaging, tissue segmentation, and multiplex cellular phenotyping for tumor microenvironment analysis Florian FARCETTE, Horsholm, Denmark David MASON, Horsholm, Denmark Stand 2 Cancer immunology
|
P32 - Discovering nucleic acid-based adjuvants for parallel stimulation of dendritic cells and liver non-parenchymal cells Yanira ZEYN, Mainz, Germany Stand 5 Dendritic and myeloid cells
|
OS16 - Crosstalk between lymphatic endothelial cells and immune cells in lymphoid organs Shadrack OWUSU, Strasbourg, France Stand 6 Dendritic and myeloid cells
|
|
P06 - Defining the role of Kupffer cells in the pathophysiology of acute liver failure
Caroline CHABAT-COURRÈDE, Paris, France
Stand 6
Dendritic and myeloid cells
|
P30 - Characterize immune response outcome in dependency on DC migration behavior Lizi TRAPAIDZE, Erlangen, Germany Stand 5 Dendritic and myeloid cells
|
P03 - The mRNA binding protein KSRP limits inflammatory response of macrophages Vanessa BOLDUAN, Mainz, Germany Stand 6 Dendritic and myeloid cells
|
P15 - Comparative analysis of human dendritic cell responses to extra- and intracellular bacteria Tomasz KASZUBOWSKI, Erlangen, Germany Stand 6 Dendritic and myeloid cells
|
P20 - Characterization of Dendritic Cell development and function in Multiple Myeloma Johannes MORSCHL, Heidelberg, Germany Stand 6 Dendritic and myeloid cells
|
|
P26 - Deciphering the molecular mechanisms involved in sepsis induced DC depletion and impaired DC development
Mathew SALAZAR, Heidelberg, Germany
Stand 5
Dendritic and myeloid cells
|
P13 - Type I IFN-signaling determines fate of neutrophil progenitors in head and neck cancer Nastassia KABANKOVA, Essen, Germany Stand 6 Dendritic and myeloid cells
|
P09 - RUFY3 regulates endolysosomes perinuclear positioning, antigen presentation and migration in activated phagocytes Evelina GATTI, Marseille, France Dendritic and myeloid cells
|
P31 - The mycotoxin Beauvericin exhibits immunostimulatory effects on dendritic cells via activating the TLR4 signaling pathway Xiaoli YANG, Düsseldorf, Germany Stand 5 Dendritic and myeloid cells
|
P18 - Dendritic cells are involved in the resolution of inflammation by IVIg in arthritis Christian H.k. LEHMANN, Erlangen, Germany Stand 6 Dendritic and myeloid cells
|
P23 - Arginase 1 causes chronicity of Leishmania mexicana infection via the generation of a replicative macrophage niche Baplu RAI, Erlangen, Germany Stand 6 Dendritic and myeloid cells
|
|
O28 - Depletion of calcium stores and impaired calcium signaling in hyperglycemic macrophages by glucose-mediated inhibition of SERCA
Laura SCHLAUTMANN, Bonn, Germany
Stand 1
Signalling in the immune system
|
P08 - Splenic Macrophages are Important for Pathogen Clearance and Induction of T cell Responses during Malaria Julia FALKENSTEIN, Essen, Germany Stand 6 Dendritic and myeloid cells
|
P29 - The role of dendritic cells in understanding chronic viral infections with lymphocytic choriomeningitis virus (LCMV) Giorgi TCHITASHVILI, Erlangen, Germany Stand 5 Dendritic and myeloid cells
|
P19 - Immunogenicity of therapeutic antibodies: role of aggregation in T lymphocyte response Maria LTEIF, Orsay, France Stand 6 Dendritic and myeloid cells
|
|
O03 - Identification of RORyt-expressing dendritic cell-like cells with distinct tissue distribution and functional properties across age
Hamsa NARASIMHAN, Munich, Germany
Stand 6
Dendritic and myeloid cells
|
P21 - An IL-7 dependent rheostat drives hypo-inflammatory monocytes to dampen effector T cell responses in the tissue Andreas J. MÜLLER, Magdeburg, Germany Stand 6 Dendritic and myeloid cells
|
P24 - Impact of DCIR on IgG-dependent DC activation Carolina Daniela RIEMER, Erlangen, Germany Stand 6 Dendritic and myeloid cells
|
P05 - A characterization of the lung macrophage and dendritic cell compartment in allergic airway inflammation following Influenza A virus infection comparing peripheral versus respiratory sensitization Belinda CAMP, Magdeburg, Germany Stand 6 Dendritic and myeloid cells
|
P12 - Early T-cell activation after recombinant Adeno-Associated Virus delivery Lindsay JEANPIERRE, Evry, France Stand 6 Dendritic and myeloid cells
|
P01 - Regulating vaccine responses by TNF at the level of C-type lectin receptor expression Robert BLAMBERG, Erlangen, Germany Stand 6 Dendritic and myeloid cells
|
P22 - Optimized method for simultaneous isolation of human dendritic cell subsets from peripheral blood Fanny ONODI, Paris, France Stand 6 Dendritic and myeloid cells
|
O02 - A distinct stimulatory cDC1 subpopulation amplifies CD8+ T cell responses in tumors for protective anti-cancer immunity Philippa MEISER, Munich, Germany Stand 6 Dendritic and myeloid cells
|
P28 - Control of neutrophil effector function by the actin-regulatory protein coronin 1a Anton SHAVERSKYI, Hannover, Germany Stand 5 Dendritic and myeloid cells
|
P02 - Autocrine function for hepcidin in Kupffer Cells during iron overloading Margault BLANCHET, Paris, France Stand 6 Dendritic and myeloid cells
|
|
P17 - Contribution of A1/Bfl-1 to regulation of myeloid cell survival
Susanne KIRSCHNEK, Freiburg, Germany
Stand 6
Dendritic and myeloid cells
|
P25 - Differential Effects of Exogenous and Endogenous Aryl Hydrocarbon Receptor Ligands on Dendritic Cell Phenotype and Function: Insights into Immune Regulation Atefeh SADEGHI SHERMEH, Erlangen, Germany Stand 5 Dendritic and myeloid cells
|
|
P14 - The role of C5aR2 in crosstalk between NK cells and dendritic cells in pregnancy
Katja KÄHLER, Lübeck, Germany
Stand 6
Dendritic and myeloid cells
|
P10 - Type 2 conventional dendritic cells differentially influence the course of cutaneous leishmaniasis in L. major- versus L. mexicana-infected mice Tobias GOLD, Erlangen, Germany Stand 6 Dendritic and myeloid cells
|
O01 - XCR1 expression licenses anti-viral effector functions of human conventional dendritic cells type 1 Lukas HEGER, Erlangen, Germany Stand 6 Dendritic and myeloid cells
|
O05 - Epidermal maintenance of Langerhans cells relies on autophagy-regulated lipid metabolism Raquel SAL CARRO, Strasbourg, France Stand 6 Dendritic and myeloid cells
|
OS20 - Platelet transfusion-related immunomodulation in mice: shift in monocyte/macrophage populations during refractoriness in mice Gabriel ROJAS-JIMÉNEZ, Strasbourg, France Stand 6 Dendritic and myeloid cells
|
OS01 - Enhanced inflammatory signaling driven by metabolic switch in Aicardi-Goutières syndrome Maxime BATIGNES, Paris, France Stand 6 Dendritic and myeloid cells
|
P11 - Role of β2 integrins on dendritic cells in immunosenescence Christoph HIEBER, Mainz, Germany Stand 6 Dendritic and myeloid cells
|
P04 - Bactericidal/Permeability-Increasing Protein Instructs Dendritic Cells to Elicit Th22 Cell Response Sigrid BÜLOW, Regensburg, Germany Stand 6 Dendritic and myeloid cells
|
|
P27 - Homeostatic signals regulating the age-dependent functions of conventional dendritic cells in murine spleen
Barbara SCHRAML, Munich, Germany
Stand 5
Dendritic and myeloid cells
|
P07 - Inflammasome responses and hyperactivation in primary human DC subpopulations Diana DUDZIAK, Jena, Germany Stand 6 Dendritic and myeloid cells
|
P16 - Myeloid cells in a mouse model of genital chlamydial infection Susanne KIRSCHNEK, Freiburg, Germany Stand 6 Dendritic and myeloid cells
|
O44 - Endosome dysfunction leads to gain-of-function TLR7 and human lupus Fabian HAUCK, Munich, Germany Stand 3 Human inborn errors of immunity
|
P210 - Division of labor and cooperation between different butyrophilin proteins in phosphoantigen-mediated activation of Vγ9Vδ2 T cells Thomas HERRMANN, Würzburg, Germany Stand 5 Innate T cells
|
O35 - Context- and subset-dependent activation of NK cells by interleukin-33 in tumors Lara REVOL-BAUZ, Lyon, France Stand 2 Cancer immunology
|
O41 - IL-23 inhibitors in psoriasis, what are the effects on local and systemic immune responses? Ikram MEZGHICHE, Paris, France Stand 5 Innate T cells
|
O39 - Ligand identification for an invariant Vδ1+ γδ T cell receptor in the context of CMV infection Rixa-Mareike KÖHN, Hamburg, Germany Stand 5 Innate T cells
|
|
O29 - NEK7 accelerates NLRP3 inflammasome activation
Svenja WOEHRLE, Freiburg, Germany
Stand 1
Signalling in the immune system
|
|
P212 - Epithelial IRF1 shapes the intraepithelial lymphocyte compartment in the murine small intestine
Tamara LEUPOLD, Erlangen, Germany
Stand 5
Innate T cells
|
O36 - Intrinsic factors and CD1d1 but not CD1d2 expression levels control NKT cell differentiation into NKT1, NKT2, and NKT17 subsets Kamel BENLAGHA, Paris, France Stand 5 Innate T cells
|
|
P211 - Fetal-derived γδ T cells show dynamic postnatal maturation patterns in preterm neonates and expand upon neonatal sepsis
Ximena LEON LARA, Hannover, Germany
Stand 5
Innate T cells
|
O40 - Antibody-dependent cytotoxicity of CD16+ T cells Nadja KÜCHLER, Homburg, Germany Stand 5 Innate T cells
|
P43 - The function of the glucose transporter type l in human antibody-secreting plasma cells Mrika ZAGRADA, Erlangen, Germany Stand 5 Neuroimmunology
|
O11 - Mast cells link immune sensing to antigen avoidance behavior Thomas PLUM, Heidelberg, Germany Stand 5 Neuroimmunology
|
|
P36 - Microglia progenitors rely on integrin-extracellular matrix interactions to colonize the developing central nervous system
Katrin KIERDORF, Freiburg, Germany
Stand 5
Neuroimmunology
|
P38 - Interactions between Macrophages and Sensory Neurons during Arboviral Infections Coralie MOLLARD, Strasbourg, France Stand 5 Neuroimmunology
|
P34 - Sex-specific response of peripheral immune cells to dopaminergic stimulation Leonie FLEIGE, Dortmund, Germany Stand 5 Neuroimmunology
|
|
P33 - IL-1-induced DNA double-strand breaks in hippocampal neurons drive cognitive deficits upon chronic brain inflammation
Marcy BELLOY, Toulouse, France
Stand 5
Neuroimmunology
|
O09 - An integrated brain-to-skin pathway promotes dermal macrophages healing properties Guillaume HOEFFEL, Marseille, France Stand 5 Neuroimmunology
|
P37 - Dss-Induced Chronic Colitis Promotes A Regional Immune Response And Neuropathology In The Central Nervous System Rebecca Katharina MASANETZ, Erlangen, Germany Stand 5 Neuroimmunology
|
P41 - Studying T cell-driven vasculitis of the central nervous system in the BrEndO mouse model Björn RISSIEK, Hamburg, Germany Stand 5 Neuroimmunology
|
|
P39 - B cell activating factor associates with treatment response in multiple sclerosis patients
Elisabeth PÖSSNECKER, Basel, Switzerland
Stand 5
Neuroimmunology
|
OS18 - Developing an innervated and immunocompetent 3D tissue model of the human olfactory mucosa Annia PEREZ RIVERON, Strasbourg, France Stand 5 Neuroimmunology
|
P40 - Cell-Based Assay for the Detection of Anti- MuSK Antibodies in Myasthenia Gravis Patients’ Sera Rachida RAACHE, Alger, Algeria Stand 5 Neuroimmunology
|
O12 - CSF-related metabolic switch with specific clonal amplification of pathogenic T and B cell subsets in early MS patients Stephane RODRIGUEZ, Rennes, France Stand 5 Neuroimmunology
|
|
P42 - Compartment locked FcRn silenced IL-12Fc allows local glioma therapy with minimal systemic inflammatory cytokine footprint
Johannes VOM BERG, Schlieren, Switzerland
Stand 5
Neuroimmunology
|
O07 - Impact of Toxoplasma gondii chronic CNS infection on microbiota-specific responses and intestinal homeostasis Alexis AUDIBERT, Toulouse, France Stand 5 Neuroimmunology
|
|
P35 - Peptide-coupled RBCs as treatment for autoimmune diseases – dissecting the mechanisms of immune tolerance induction
Vasileia KALAITZAKI, Schlieren, Switzerland
Stand 5
Neuroimmunology
|
O08 - Astrocytic NF-kappaB shapes the CNS immune environment and induces an aging-like phenotype Tabea Melissa HEIN, Ulm, Germany Stand 5 Neuroimmunology
|
P143 - Metabolic profiling of human memory T cells in adenoids Christopher NEULLENS, Aachen, Germany Stand 1 Signalling in the immune system
|
|
O21 - Stiffness-induced cancer-associated fibroblasts are responsible for immunosuppression in a PDGF ligand-dependent manner
Mélissa MASMOUDI, Lyon, France
Stand 5
Structural immunity: Stroma-immune crosstalk
|
OS17 - Study of human mesenchymal-hematopoietic cell crosstalk to model chronic inflammatory settings Guillermo Federico PEREZ, Strasbourg, France Stand 5 Structural immunity: Stroma-immune crosstalk
|
P139 - Targeting Innate-mediated Signaling for Treatment of Multiple Sclerosis Antonios KATSOULAS, Schlieren, Switzerland Stand 1 Signalling in the immune system
|
|
P127 - Novel matrix-targeting tenascin-C-inhibitory agents support anti-tumor immunity
Amanpreet KAUR, Strasbourg, France, France
Stand 5
Structural immunity: Stroma-immune crosstalk
|
P122 - Deciphering the implication of lymph nodes stromal cells in autoimmune responses during Systemic Lupus Erythematosus Annaïck AIROLDI, Strasbourg, France Stand 5 Structural immunity: Stroma-immune crosstalk
|
O04 - Modulation of autophagy affects ADCC in a tissue-specific manner Mathilde NUGUE, Paris, France Stand 6 Dendritic and myeloid cells
|
P137 - Immunomodulation Induced By The Minor Subpocket Of Cxcr4 In B Cells Stéphane GIORGIUTTI, Strasbourg, France Stand 1 Signalling in the immune system
|
O26 - The role of Sprouty 1 and 2 in CD4+ T memory cell differentiation Pallavi KADAM, Munich, Germany Stand 1 Signalling in the immune system
|
|
P126 - Impact of stromal cells on the adaptation and expansion of tissue-resident Tregs
Svetlina GEORGIEVA, Braunschweig, Germany
Stand 5
Structural immunity: Stroma-immune crosstalk
|
P149 - LiBOD – Liquid Biopsy in Organ Damage – small extracellular vesicle chip-based assessment of polytrauma Rebekka SALZMANN, Bonn, Germany Veronika LUKACS-KORNEK, Bonn, Germany Stand 1 Signalling in the immune system
|
P130 - Spatial profiling in lymphoid organs using CODEX technology Ramona REICHELT, Bonn, Germany Stand 5 Structural immunity: Stroma-immune crosstalk
|
|
P132 - Transcriptional regulator DC-SCRIPT dampens type I interferon expression
Shafaqat ALI, Duesseldorf, Germany
Stand 1
Signalling in the immune system
|
P145 - Molecular determinants and transcriptional and epigenetic basis of glutamate dehydrogenase-PGE2-dependent Treg cell development Fabien PRODJINOTHO, Munich, Germany Stand 1 Signalling in the immune system
|
|
P125 - O-glycosylation in lymphatic endothelial cells contributes to the formation of the CD169+ sinusoidal macrophage population in the mouse lymph node
Jasmin FREY, Zurich, Switzerland
Stand 5
Structural immunity: Stroma-immune crosstalk
|
P134 - Influence of phospho-Vitamin C on γδ T cell activity Lea M. CIERNA, Kiel, Germany Stand 1 Signalling in the immune system
|
|
P131 - CD169+ macrophages orchestrate immune modulation and matrix deposition in pancreatic cancer
Kevin THIERRY, Lyon, France
Stand 5
Structural immunity: Stroma-immune crosstalk
|
P150 - Role of ZEB2 in the function of antigen-specific human CD8+ T cells Varun SASIDHARAN NAIR, Braunschweig, Germany Stand 1 Signalling in the immune system
|
P148 - Deficiency of deubiquitinating enzyme OTUB1 leads to impaired pathogen control in macrophages during Salmonella infection Isita SAGAR, Hannover, Germany Stand 1 Signalling in the immune system
|
P136 - Induction of the UPR by the subtilase cytotoxin drives IFN-β expression – the search for the mechanism of action in human pDCs Evelina GATTI, Marseille, France Signalling in the immune system
|
P123 - Dietary lipids accumulate in mesenteric lymph node cells and influence oral tolerance induction Manuela BÜTTNER, Hannover, Germany Stand 5 Structural immunity: Stroma-immune crosstalk
|
O20 - Identification of a novel myeloid precursor after stimulation with RANKL, a stroma-produced cytokine Alice LAVANANT, Strasbourg, France Stand 5 Structural immunity: Stroma-immune crosstalk
|
|
O22 - Spatio-temporal characterization of lymphoid structures in IBD
Mathilde POHIN, Oxford, United Kingdom
Stand 5
Structural immunity: Stroma-immune crosstalk
|
P140 - The effects of protein succinylation on osteoclastogenesis Katharina KUBATZKY, Heidelberg, Germany Stand 1 Signalling in the immune system
|
P124 - Development of a Vδ1 T cell-competent organotypic 3D human skin model Charlotte ESSER, Düsseldorf, Germany Stand 5 Structural immunity: Stroma-immune crosstalk
|
P146 - Functional Characterization Of Guanylate Binding Proteins In The Innate And Adaptive Host Defense Against Chlamydia And Toxoplasma Infection Veronica RABA, Düsseldorf, Germany Stand 1 Signalling in the immune system
|
P142 - Cytokine pathways in the pathogenesis of idiopathic Multicentric Castleman Disease Ilgiz A. MUFAZALOV, Mainz, Germany Stand 1 Signalling in the immune system
|
OS12 - Post translational modifications of IL-1β; regulation and roles in IL-1β activation Danielle Paige ANTHONY, Freiburg, Germany Stand 1 Signalling in the immune system
|
|
P147 - Spatio-temporal analysis of subcellular LAT signaling modules
Juan Jose SAEZ PONS, Paris, France
Stand 1
Signalling in the immune system
|
P138 - Simplifying High-Parameter Phenotypic and Functional Characterization of Cancer Immune Cells Emilie GREGORI, Paris, France Stand 1 Signalling in the immune system
|
OS14 - Stromal microenvironment in common variable immunodeficiency Victoria COUSIN, Freiburg, Germany Stand 5 Structural immunity: Stroma-immune crosstalk
|
O19 - Generation of functional human thymic organoids promoting multilineage differentiation of mature dendritic and CD4/CD8 T cells Matthieu GIRAUD, Nantes, France Stand 5 Structural immunity: Stroma-immune crosstalk
|
O23 - Lung stromal dysregulation by excess dietary lipids Sophia ROTTMANN, Bonn, Germany Stand 5 Structural immunity: Stroma-immune crosstalk
|
|
P133 - The atypical NF-κB modulator IκBNS is differently required for T follicular helper cell differentiation in spleen and Peyer’s Patches
Andre CARMO-FERNANDES, Bochum, Germany
Stand 1
Signalling in the immune system
|
P135 - NCOR1 controls Treg subset differentiation and effector function Rafael FREITAS E SILVA, Vienna, Austria Stand 1 Signalling in the immune system
|
P141 - Syntenin-1-mediated arthritogenicity is advanced by reprogramming Rheumatoid Arthritis metabolic macrophages and Th1 cells Anja MEYER, Chicago, United States Stand 1 Signalling in the immune system
|
P128 - Synovial landscape unravels immune-stromal networks linking inflammation to fibrosis in osteoarthritis. Damien LAOUTEOUET, Montpellier, France Florence APPARAILLY, Montpellier, France Stand 5 Structural immunity: Stroma-immune crosstalk
|
P129 - Identifying the stromal KIT ligand (SCF) sources that maintain mast cell homeostasis in tissues Paloma MARTZLOFF, Freiburg, Germany Stand 5 Structural immunity: Stroma-immune crosstalk
|
P151 - Deficiency of the deubiquitinating enzyme Cylindromatosis (CYLD) protects against S. aureus infection Christina SCHMIDT, Hannover, Germany Stand 1 Signalling in the immune system
|
P144 - Regulation of the humoral immune response by glucose Katharina PRACHT, Erlangen, Germany Stand 1 Signalling in the immune system
|
|
OS04 - Role of IL-36RA mutations in Crohn’s disease
Julia HECKER, Berlin, Germany
Stand 1
Signalling in the immune system
|
P79 - Donor T and NK cells with a special tissue-resident memory phenotype migrate into the periphery of lung transplant recipients – a potential feature for tolerance development Christine S. FALK, Hannover, Germany Stand 4 T cells
|
|
P97 - T cell aging deciphered: a comprehensive study of aging-related adaptations in murine intestinal T cells
Martina PALATELLA, Braunschweig, Germany
Stand 4
T cells
|
O32 - SLAMF7 (CD319) lowers the threshold for differentiation commitment of cytotoxic T lymphocytes Holger LINGEL, Magdeburg, Germany Stand 2 Cancer immunology
|
P82 - A distinct T cell receptor signature associates with cardiac functional outcomes in myocardial infarction patients Kenz LE GOUGE, Paris, France Stand 4 T cells
|
|
P91 - Revisiting old questions of T-cell receptor α- and β-chain regulation for development of next-generation cell therapies
Carolin MOOSMANN, Erlangen, Germany
Stand 4
T cells
|
P60 - Liver sinusoidal endothelial cells limit antiviral CD8 T cell immunity in a tissue-rheostat-like fashion Anna FÜRST, Munich, Germany Stand 3 T cells
|
P45 - EBI2 marks CD8+ tissue-resident memory T cells of the skin Lucas ARENDHOLZ, Heidelberg, Germany Stand 3 T cells
|
P47 - Differences of DNA methylation and chromatin accessibility during human skin Treg differentiation Niklas BEUMER, Heidelberg, Germany Stand 3 T cells
|
P62 - Compromised T cell development in children with complex congenital heart disease Anna GIERAS, Hamburg, Germany Stand 3 T cells
|
P48 - Fast and easy: isolation of functional immune cells straight from mouse spleen Amelie BORCZEWSKI, Bergisch Gladbach, Germany Stand 3 T cells
|
O15 - CD25+FOXP3+ regulatory T-cells control pancreatic tissue remodeling by suppression of the type-2 immune response Juliane GLAUBITZ, Greifswald, Germany Stand 3 T cells
|
|
P58 - Ex vivo metabolic profiling of human antigen-reactive T cells after yellow fever vaccination
Sina FRISCHHOLZ, Erlangen, Germany
Stand 3
T cells
|
|
P109 - Antigen-specific T-cell responses after at least 130 SARS-CoV-2 vaccinations - a case study
Ev-Marie SCHUSTER, Erlangen, Germany
Stand 4
T cells
|
P104 - Differently manufactured Arnica montana L. extracts mediate anti-inflammatory effects on human T cells via different signaling pathways Yvonne SAMSTAG, Heidelberg, Germany Stand 4 T cells
|
O33 - Modulating T cell signaling to improve anti-tumor responses. Vasileios MORFOS, Freiburg, Germany Stand 2 Cancer immunology
|
P65 - 50-Parameter Flow Cytometry by CyTOF Empowers Comprehensive Single-Cell Immune Profiling of Pulmonary Immunosenescence in Aged Mice Emilie GREGORI, Paris, France Stand 3 T cells
|
P88 - Chronic heart failure associates with enhanced activation and clonal expansion of potential autoreactive T cells Maximilian MERTEN, Frankfurt Am Main, Germany Stand 4 T cells
|
P84 - Aging and viral evolution impair dominant pan-coronavirus-reactive immunity against SARS-CoV-2 Lucie LOYAL, Berlin, Germany Stand 4 T cells
|
P105 - CMIP requirement in T Follicular helper cell highlights its role in the immunopathogenesis of Idiopathic Nephrotic Syndrome Berkan SAVAS, Lyon, France T cells
|
O18 - HIF-1a-mediated mitochondrial-glycolytic reprogramming controls the transition of precursor to terminally exhausted T cells Hao WU, Wuerzburg, Germany Stand 3 T cells
|
OS19 - Mucosal T cell immunity: MR1-restricted T cells in chronic intestinal inflammation Vanshika RASTOGI, Basel, Switzerland Stand 3 T cells
|
|
P78 - Functionality of antigen-specific T-cell receptor repertoires after SARS-CoV-2 vaccination
Katharina KOCHER, Erlangen, Germany
Stand 4
T cells
|
P74 - The proteasome regulator PA28αβ is a crucial determinant in graft acceptance Kaharina INHOLZ, Konstanz, Germany Stand 3 T cells
|
P119 - TBKBP1 is a novel player modulating the cytotoxic function of human cytomegalovirus-specific CD8+ T cells Zheng YU, Braunschweig, Germany Stand 4 T cells
|
P72 - Zfp362 plays a redundant role for Th17 cell development and function Lisa HOENICKE, Braunschweig, Germany Stand 3 T cells
|
P54 - Identification & characterization of virus-specific T cell epitopes in SARS-CoV-2 vaccinated and/or convalescent individuals reveals immunization route – dependent reactivity pattern. Charlyn DÖRNTE, Bergisch Gladbach, Germany Stand 3 T cells
|
P95 - The effect of ubiquitin and ubiquitin-like modifier on DRiP Synthesis Natalie PACH, Konstanz, Germany Stand 4 T cells
|
P89 - PLGA-Microsphere based T-cell vaccination against Influenza A virus Dennis MINK, Konstanz , Germany Stand 4 T cells
|
O34 - SLAMF7-signals induce resistance against apoptosis in activated CD8+ T-cells Anastasia ORLOV, Magdeburg, Germany Stand 2 Cancer immunology
|
P67 - Creb Regulates Foxp3+St-2+ Tregs With Enhanced Il-10 Production Sudheendra HEBBAR SUBRAMANYAM, Aachen, Germany Stand 3 T cells
|
OS06 - FAS-controlled T cells undergo normal thymic selection and can differentiate from a broad range of early-differentiated peripheral CD4+ or CD8+ T cells Christoph KOENIG, Freiburg, Germany Stand 3 T cells
|
OS25 - Mass cytometry-based immune profiling of human Peyer's patches In Crohn’s disease Adrian HUCK, Berlin, Germany Stand 3 T cells
|
|
P70 - Identifying parameters correlating with pdFVIII+LPS-induced synergistic cell activation.
Jessica HERZIG, Langen, Germany
Stand 3
T cells
|
P113 - TGF-beta supports intestinal epithelial integrity by its action on T cells Valentin THEVIN, Lyon 08, France Stand 4 T cells
|
P51 - Pro-inflammatory innate-like T cells are expanded in the blood and inflamed intestine in Crohn´s Disease Cristina Maria CHIAROLLA, Würzburg, Germany Stand 3 T cells
|
|
P108 - IkBNS regulates regulatory T cell responses during Leihmania major infection
Ingo SCHMITZ, Bochum, Germany
Stand 4
T cells
|
P110 - TNF: Friend or Foe of Fox P3+ Naive and Effector Regulatory T Cells? Nainisha SHAH, Montpellier , France Stand 4 T cells
|
P115 - Liver immunity index: circulating HBV-specific CXCR6+ CD8 T-cells mirror intrahepatic anti-viral T cell immunity and predict immune control in models of chronic hepatitis B Hannah WINTERSTELLER, Munich, Germany Stand 4 T cells
|
P112 - The role of T lymphocytes in lupus disease re-examined using a spontaneously-mutated MRL/lpr mouse Laura TALAMINI, Strasbourg , France Stand 4 T cells
|
P92 - Highly scalable and automation-compatible organ-on-chip platform Sebastien MOSSER, Oulu, Finland Stand 4 T cells
|
O27 - Engagement of co-stimulatory receptors differentially shapes the architecture of the CD8+ T cell immunological synapse Guilhèn PRUNIER, Toulouse, France Stand 1 Signalling in the immune system
|
P64 - Vascular leakage: Analyzing mechanisms behind a severe side effect with an irAOP as tool Patricia GOGESCH, Langen, Germany Stand 3 T cells
|
P53 - Enolase 1 of Candida albicans binds human CD4 and modulates both naïve and memory T cell responses Niklas BEYERSDORF, Würzburg, Germany Stand 3 T cells
|
|
O10 - Evaluating the pathogenicity of T cells in Alzheimer's disease and other tauopathies
Karen MATTA, Paris, France
Stand 5
Neuroimmunology
|
P98 - Ripk1 is essential to maintain the suppressive capacity of effector Treg cells Carlos PLAZA SIRVENT, Bochum, Germany Stand 4 T cells
|
P68 - Diverging mechanisms of HBV-specific CD8+ T-cell dysfunction in chronic HBV infection Kathrin HEIM, Freiburg, Germany Stand 3 T cells
|
P63 - CD73-expressing DP8a Tregs prevent acute GvHD Margaux VERDON, Nantes, France Stand 3 T cells
|
O37 - Evaluation of immune T-cells responsible for tissue repair in human liver transplantation and in a mouse model of hepatic ischemia reperfusion Romain BOST, Poitiers, France Stand 5 Innate T cells
|
P86 - Acid ceramidase expression maintains B cell numbers and reduces IFN-gamma secretion by CD4+ T cells in mice Putri MANDASARI, Wuerzburg, Germany Stand 4 T cells
|
P66 - Establishment of an RSV reinfection model with the focus on CD8+ tissue-resident memory T cells and their proteomic profile Christoph HAASE, Bochum, Germany Stand 3 T cells
|
P69 - Primary ChAdOx1 vaccination fails to reactivate pre-existing, cross-reactive T cells Lucie LOYAL, Berlin, Germany Stand 3 T cells
|
P80 - Differently prepared Chamomilla recutita L. extracts and corresponding lead compounds diminish proinflammatory responses of primary human T cells Divya LAIRIKYENGBAM, Heidelberg, Germany Stand 4 T cells
|
|
P107 - Superantigen and allergy: Type 2 memory against SEB in healthy and atopic individuals
Frieder SCHMIEDEKE, Greifswald, Germany
Stand 4
T cells
|
P93 - Regulatory T cell-dependent maintenance of memory T helper cells in vivo Sano NAGANO, Yonago, Japan Stand 4 T cells
|
P76 - Generation of antigen-specific CD4+CD25+ regulatory Tcells, challenges and approaches Priska JOST, 66421 Homburg, Germany Stand 4 T cells
|
|
P96 - A one-pot technology for simultaneous assessment of peptide-MHC binding and antigen-reactivity in CD8 T cells towards large peptide libraries
Nikolaj PAGH KRISTENSEN, Kgs. Lyngby, Denmark
Stand 4
T cells
|
P111 - SMAD4 TGF-β-independent function dictates naive CD8+ T cell fate and prevents gut inflammation Saidi SOUDJA, Lyon, France Stand 4 T cells
|
P50 - Streamlining T and B Cell Isolation: Introducing the REAlease Technology for Fast and Reliable Cell Purification from Whole Blood Vanessa BRÜHL, Bergisch Gladbach, Germany Stand 3 T cells
|
P94 - Complement protein C3a enhances adaptive immune responses towards FVIII products Samira ORTEGA IANNAZZO, Langen, Germany Stand 4 T cells
|
P116 - The ATP receptor P2X7 mediates cell death in human unconventional and tissue-resident T lymphocytes Riekje WINZER, Hamburg, Germany Stand 4 T cells
|
|
P87 - Id2 promotes the differentiation and effector functions of T resident memory cells while repressing CD8 T cell exhaustion during CNS chronic pathogen infection
Frederick MASSON, Toulouse Cedex 3, France
Stand 4
T cells
|
P120 - Selective ablation of thymic and peripheral Foxp3+ regulatory T cell development Dimitra Maria ZEVLA, Dresden, Germany Stand 4 T cells
|
P85 - Role of Estrogen receptor signaling in the activation and differentiation of human CD4+ T cells Alisier MALARD, Berlin, Germany Stand 4 T cells
|
OS23 - Role of Ikaros in the regulation of Th17 cells differentiation Caroline TARGINO ALVES DA SILVA, Illkirch, France Stand 3 T cells
|
|
P77 - AKNA is a novel RNA-binding protein and regulates immune responses at the centrosome
Lisa KIFINGER, Munich, Germany
Stand 4
T cells
|
P101 - Single cell transcriptomic signature of three distinct liver-self-antigen specific CD4 T cell reactivities Amedee RENAND, Nantes, France Stand 4 T cells
|
P117 - Comparative analysis of Roquin-1 and Regnase-1 binding to the T cell transcriptome defines evolutionary conservation, modes of regulation and uncovers novel roles in lymphocyte differentiation Elaine WONG, Planegg-Martinsried, Germany Stand 4 T cells
|
P106 - Ketogenic Diet: A Tool for Remodeling human Treg and Th17 Immunometabolism Annika SCHMID, Munich, Germany Stand 4 T cells
|
|
P75 - Development of a CRISPR/Cas9 system for functional studies of murine and human T cell and monocyte populations
Nouria JANTZ-NAEEM, Magdeburg, Germany
Stand 3
T cells
|
P100 - Impact of microbiota on immune cell subset composition and activation status in kidneys Shafaque RAHMAN, Braunschweig, Germany Stand 4 T cells
|
P103 - Immune tolerance to liver-targeted antigen is mediated by a dysfunctional Th1-like CD4+ T cell population Hanadi SALIBA, Evry-Courcouronnes, France Stand 4 T cells
|
P55 - Unleashing Synergistic T Cell Power: Novel Insights into Cooperative Killing of Virus-Infected Hepatocytes by Conventional and Auto-Aggressive CD8 T Cells Ariane ECEIZA, Munich, Germany Stand 3 T cells
|
O16 - Cell-intrinsic ceramide concentrations determine CD8+ T cell function in vitro and in vivo Matthias HOSE, Essen, Germany Stand 3 T cells
|
P118 - Opposing Roles of Thymus-Derived Foxp3+ Regulatory T Cells in the Control of Beta Cell Autoimmunity and Adipose Tissue Homeostasis Acelya YILMAZER KIRGIN, Dresden, Germany Stand 4 T cells
|
P102 - CyTOF-based detailed characterization of virus specific CD4+ T cells after cure from severe COVID-19 without specific humoral immunity Addi Josua ROMERO OLMEDO, Marburg, Germany Stand 4 T cells
|
|
P59 - The role of immune checkpoint molecules in control of cytomegalovirus-specific T cells
Lea FRITZ, Hannover, Germany
Stand 3
T cells
|
P73 - Sustained gp130 signaling in T cells causes unrestricted TH17 cell responses, severe lung inflammation and increased bone porosity Emily Valentina Madelaine HUTH, Hamburg, Germany Stand 3 T cells
|
P57 - Epigenetic-driven differentiation of antigen-specific regulatory T cells from human induced pluripotent stem cell (hiPSC) Marcel FINKE, Berlin, Germany T cells
|
P61 - Impact of plasma kallikrein on CD4+ T cell function Nadine GAUSMANN, Essen, Germany Stand 3 T cells
|
P99 - SARS-CoV2 mRNA-vaccination-induced Immunological Memory in Human Non-Lymphoid and Lymphoid Tissues Vanessa PROß, Berlin, Germany Stand 4 T cells
|
P71 - Characterization of ExTregs in vivo revealing regulatory T-cell instability at steady state and in cancers Morgane HILAIRE, Paris, France Stand 3 T cells
|
P114 - Histone deacetylases 1 and 2-mediated control of intestinal CD4+ T cell immunity Phuc TRAN HUU, Vienna, Austria Stand 4 T cells
|
P44 - Characterization of long non-coding RNA controlling regulatory T cell identity Véronique ADOUE, Toulouse, France Stand 3 T cells
|
P49 - Enlarged Th17 and diminished NK T cell populations in conditional Adam10 knockout mice Peter BRADTKE, Hamburg, Germany Stand 3 T cells
|
P83 - Epigenetic editing for conventional to regulatory T cell reprogramming Ramonique LIM, Berlin, Germany Stand 4 T cells
|
O38 - Assessing the metabolic requirements of MAIT cells during development Prerna GAMBHIR, Giessen, Germany Stand 5 Innate T cells
|
|
P56 - CD4+ Th1 cells induce the generation of auto-aggressive CD8 T cells through IL-2 and IL-21
Jonas FACKLER, Munich, Germany
Stand 3
T cells
|
P46 - Regulatory T cells require IL-6 receptor alpha signaling to control skeletal muscle function and regeneration Maike BECKER, Munich, Germany Stand 3 T cells
|
|
O25 - Optogenetic approaches uncover how the kinetics of the antigen-TCR interaction impact on T cell activation and differentiation
Wolfgang SCHAMEL, Freiburg, Germany
Stand 1
Signalling in the immune system
|